Product NDC: | 59011-255 |
Proprietary Name: | Intermezzo |
Non Proprietary Name: | zolpidem tartrate |
Active Ingredient(s): | 3.75 mg/1 & nbsp; zolpidem tartrate |
Administration Route(s): | SUBLINGUAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59011-255 |
Labeler Name: | Purdue Pharma LP |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022328 |
Marketing Category: | NDA |
Start Marketing Date: | 20120405 |
Package NDC: | 59011-255-05 |
Package Description: | 5 CARTON in 1 TRAY (59011-255-05) > 1 POUCH in 1 CARTON > 1 TABLET in 1 POUCH |
NDC Code | 59011-255-05 |
Proprietary Name | Intermezzo |
Package Description | 5 CARTON in 1 TRAY (59011-255-05) > 1 POUCH in 1 CARTON > 1 TABLET in 1 POUCH |
Product NDC | 59011-255 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | zolpidem tartrate |
Dosage Form Name | TABLET |
Route Name | SUBLINGUAL |
Start Marketing Date | 20120405 |
Marketing Category Name | NDA |
Labeler Name | Purdue Pharma LP |
Substance Name | ZOLPIDEM TARTRATE |
Strength Number | 3.75 |
Strength Unit | mg/1 |
Pharmaceutical Classes | gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [Chemical/Ingredient],Central Nervous System Depression [PE] |